Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease

NCT03040674 is registered in ClinicalTrials.gov with Lung Institute as lead sponsor.

NCT NCT03040674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03040674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease
Lead sponsor
Lung Institute
Phase
Observational
Overall status
Completed
Start date
January 3, 2017
Completion date
December 31, 2020
Enrollment
489 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, interstitial lung disease